NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/23/2024
Back to search
Official data from USPTO
NEURO EYE CLINICAL TRIALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEURO EYE CLINICAL TRIALS
ST13
US500000097621316Class
42
Filing
97621316
Registration
7290852
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
01/23/2024
Trademark type
Word
Nice classes
42
Filing date
10/06/2022
Registration date
01/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/23/2024
Last transaction
01/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
01/13/2017
First use in commerce
01/13/2017
Drawing code
4
Owner type
03
Owner location
Bellaire, TX
Examiner
JOHNSON, AISHA
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Neuro-Eye Clinical Trials, Inc.
R. T. (pessoa física)
J. S. (pessoa física)
Representatives
Lauren Kemps-Thibodeaux THE LAW OFFICES OF LAUREN KEMPS-THIBODEAUX, PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology
Publications
History of USPTO decisions and trademark events.
18 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/23/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/21/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/17/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/17/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/17/2023
GNRT
NON-FINAL ACTION E-MAILED
10/17/2023
CNRT
NON-FINAL ACTION WRITTEN
10/17/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/20/2023
GNRT
NON-FINAL ACTION E-MAILED
07/20/2023
CNRT
NON-FINAL ACTION WRITTEN
07/20/2023
DOCK
ASSIGNED TO EXAMINER
07/20/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/23/2022
NWAP
NEW APPLICATION ENTERED
10/10/2022
Continuous trademark protection
Get notified about every new filing that threatens NEURO EYE CLINICAL TRIALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.